Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening

University Of Pittsburgh Cancer Institute Researcher Dr. Merrill Egorin Honored With ASCO Translational Research Professorship
Merrill Egorin, M.D., professor of medicine and pharmacology at the University of Pittsburgh Cancer Institute (UPCI), has received the 2009 American Society of Clinical Oncology (ASCO) Translational Research Professorship for his work in improving cancer treatments and supporting the next generation of researchers.
generic viagra online
Arena Pharmaceuticals Announces The Presentation Of Lorcaserin Phase 3 BLOOM Data At The American Diabetes Association's 69th Scientific Sessions
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) announced that a late-breaking abstract of its lorcaserin Phase 3 BLOOM (Behavioral modification and Lorcaserin for Overweight and Obesity Management) trial has been accepted for a poster presentation at the American Diabetes Association"s 69th Scientific Sessions in New Orleans, Louisiana. The abstract, titled "Lorcaserin Reduces Body Weight in Obese and Overweight Subjects: Behavioral Modification and Lorcaserin for Overweight and Obesity Management, the BLOOM Trial," will be displayed from June 6, 2009 at 10:00 a.m. Central Daylight Time (CDT) until June 8, 2009 at 4:00 p.m. CDT in the Morial Convention Center, Hall E. The poster has been assigned presentation number 96-LB in category 20-B Obesity - Clinical Treatment.
News of the day
FTC Report On Biosimilars Is Fundamentally Flawed
The following statement was issued by Jeff Joseph, Biotechnology Industry Organization (BIO) Vice President of Communications, in response to a new report on biosimilars released today by the Federal Trade Commission (FTC):
Public Health

NEJM Perspective Provides Overview Of Recent Health Reform Action

"Building Momentum as Democrats Forge Health Care Reform," New England Journal of Medicine: In a perspective piece, John Iglehart, a national correspondent for NEJM, reviews recent action on health reform. He discusses industry and provider groups" pledge to reduce spending by $2 trillion over the next 10 years, noting that the groups" pledge was a "recognition that the pace of reform is quickening and they wanted to be a full participant in negotiations." He also addresses congressional action, including discussions of a public insurance option and how lawmakers are attempting to address the cost of reform (Iglehart, NEJM, 5/14). Reprinted with kind permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. © 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009